Continuous epidermal growth factor receptor-tyrosine kinase inhibitor administration in primary lung adenocarcinoma patients harboring favorable mutations with controlled target lung tumors dose not hinder survival benefit despite small new lesions

Ping Chih Hsu, Li Chung Chiu, Shih Hong Li, Chih Hung Chen, Chih Liang Wang, Kuo Chin Kao, John Wen Chang Chang, Chih Wei Wang, Chih Teng Yu, Fu Tsai Chung, Cheng Ta Yang, Chien Ying Liu

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint Dive into the research topics of 'Continuous epidermal growth factor receptor-tyrosine kinase inhibitor administration in primary lung adenocarcinoma patients harboring favorable mutations with controlled target lung tumors dose not hinder survival benefit despite small new lesions'. Together they form a unique fingerprint.

Medicine & Life Sciences